These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7715361)

  • 1. Treatment of children with HIV infection. PENTA (Paediatric European Network for Treatment of AIDS).
    Gibb DM; Darbyshire JH; Debré M; Giaquinto C; Aboulker JP; Martinez M; Tudor-Williams G
    Lancet; 1995 Apr; 345(8957):1115. PubMed ID: 7715361
    [No Abstract]   [Full Text] [Related]  

  • 2. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
    Englund JA; Baker CJ; Raskino C; McKinney RE; Petrie B; Fowler MG; Pearson D; Gershon A; McSherry GD; Abrams EJ; Schliozberg J; Sullivan JL
    N Engl J Med; 1997 Jun; 336(24):1704-12. PubMed ID: 9182213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination superior to zidovudine in Delta trial.
    Choo V
    Lancet; 1995 Sep; 346(8979):895. PubMed ID: 7564678
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-HIV therapy (1987-1994): from nothing to confusion].
    Lissen E
    Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
    [No Abstract]   [Full Text] [Related]  

  • 5. Testing an anti-HIV trio.
    Lancet; 1992 Mar; 339(8794):672. PubMed ID: 1347353
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.
    Commun Dis Rep CDR Wkly; 1995 Oct; 5(42):209. PubMed ID: 7496435
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of zidovudine and didanosine during combination therapy.
    Morse GD; Shelton MJ; Ho M; Bartos L; DeRemer M; Ragni M
    Antiviral Res; 1995 Aug; 27(4):419-24. PubMed ID: 8540760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
    Clay PG; Rathbun RC; Slater LN
    JAMA; 1999 Jan; 281(2):130; author reply 131. PubMed ID: 9917107
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.
    AIDS; 1998 Oct; 12(14):F151-60. PubMed ID: 9792371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
    Haubrich R; Richman D
    JAMA; 1999 Jan; 281(2):130-1. PubMed ID: 9917108
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of combined zidovudine and didanosine therapy in early asymptomatic primary HIV-1 infection.
    Khajotia RR; Feigley CE; Lee E; Gu J
    AIDS; 1998 Jan; 12(2):222-4. PubMed ID: 9468376
    [No Abstract]   [Full Text] [Related]  

  • 12. The Delta trial.
    Zaretsky MD
    Lancet; 1997 Feb; 349(9048):358-9. PubMed ID: 9024402
    [No Abstract]   [Full Text] [Related]  

  • 13. Didanosine (DDI) alone is now considered the first-line therapy for symptomatic children infected with the human immunodeficiency virus (HIV).
    J Am Osteopath Assoc; 1996 Jun; 96(6):339. PubMed ID: 8690619
    [No Abstract]   [Full Text] [Related]  

  • 14. Zidovudine therapy and HIV type 1 mutations in children with symptomatic HIV type 1 infection: effect of switching to didanosine or zidovudine plus didanosine therapy. Italian Multicenter Study Group on HIV Mutations in Children.
    Principi N; Marchisio P; Esposito S; Rossi P; Gattinara GC; Galli L; Gabiano C; Zuccotti GV; Orlandi P
    AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1653-9. PubMed ID: 9870319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of nucleoside analogues in the treatment of HIV-infected children.
    Husson RN; Pizzo PA
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1059-64. PubMed ID: 1323984
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group.
    Bozzette SA; Kanouse DE; Duan N; Berry S; Richman DD
    Antivir Ther; 1996 Jan; 1(1):21-32. PubMed ID: 11322256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Researchers report sustained suppression of HIV with nevirapine--didanosine--zidovudine.
    Am J Health Syst Pharm; 1998 Jun; 55(11):1106, 1108. PubMed ID: 9626369
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of AZT effectiveness in treating HIV-infected children halted.
    J Am Osteopath Assoc; 1995 Mar; 95(3):211. PubMed ID: 7751172
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HIV therapy lowers risk of AIDS, death in patients with intermediate-stage HIV disease.
    AIDS Patient Care; 1995 Dec; 9(6):303. PubMed ID: 11361440
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine.
    Foli A; Maserati R; Minoli L; Wainberg MA; Gallo RC; Lisziewicz J; Lori F
    AIDS; 1998 Jun; 12(9):1113-4. PubMed ID: 9662215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.